What is jbrds?
Founded in 2022, jbrds operates at the intersection of biomechanics and consumer retail. The company focuses on the critical developmental stages of infants and toddlers, addressing a significant gap in the footwear industry. By engineering the Stand2Walk shoe, jbrds provides essential support for the lateral column and the developing cuboid bone, effectively stabilizing the heel during the formative years of walking. This technical focus differentiates the brand from traditional mass-market children's footwear, positioning it as a high-authority player in the health-conscious parenting segment.
How much funding has jbrds raised?
jbrds has raised a total of $500K across 1 funding round:
Angel/Seed
$500K
Angel/Seed (2023): $500K, investors not publicly disclosed
Key Investors in jbrds
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for jbrds?
With this major enterprise-level funding, jbrds is poised to scale its manufacturing capabilities and expand its distribution footprint. The strategic roadmap likely involves deepening its research and development efforts to refine its proprietary footwear technology while simultaneously scaling its direct-to-consumer marketing channels. As the company transitions from its initial launch phase to a broader market presence, the focus will remain on establishing brand equity through clinical validation and strategic retail partnerships. The infusion of capital provides the necessary runway to solidify its market position as a leader in pediatric orthopedic-focused footwear, ensuring long-term sustainability in a competitive retail landscape.
See full jbrds company page
